Demonstrates enhanced cytotoxicity in cancer cells with lysosome-targeted transporters, suggesting new therapeutic strategies.
Targeting anion transporters to specific organelles has previously been shown to be an effective strategy to enhance their cytotoxicities against cancerous cell lines. In this work a new family of squaramide anion transporters appended with two different lysosome targeting groups via a 1,4-substituted benzene spacer were synthesised. Cell viability studies showed that the transporters containing the N,N-dimethylamine targeting group exhibited the greatest cytotoxic effects despite possessing lower transport activities than the non-targeted control compounds and those containing the morpholine targeting group. Subcellular localisation studies using anthracene-labelled squaramides found that both targeting motifs successfully directed compounds to the lysosome, but the morpholine-containing motif accumulated to a lesser extent.
No takes yet. Share an insight, caveat, or question.
Feo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: